← Back to Search

Clinical Outcomes With Bilateral Implantation of Odyssey IOLs

N/A
Recruiting
Led By Phillip Brunson, OD
Research Sponsored by Mann Eye Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
• Patients aged 50 years and older who underwent bilateral cataract surgery with Odyssey IOL implantation.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months postoperative
Awards & highlights
No Placebo-Only Group

Summary

This study is a single center, ambispective study of visual outcomes after successful bilateral cataract surgery. Subjects will be assessed at least 3 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS and OSDI questionnaires, as well as measurement of visual acuities at distance, intermediate, and near.

Eligible Conditions
  • Cataract
  • Pseudoaphakia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months postoperative
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months postoperative for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Visual Acuity at Distance (6m) logMAR
Visual Acuity at Intermediate (66cm) logMAR
Visual Acuity at Near (33cm) logMAR
+1 more
Secondary study objectives
Assessment of IntraOcular Lens Implant Symptoms (AIOLIS) Questionniare

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: TECNIS Odyssey IOLExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Mann Eye InstituteLead Sponsor
2 Previous Clinical Trials
70 Total Patients Enrolled
SengiIndustry Sponsor
25 Previous Clinical Trials
1,973 Total Patients Enrolled
13 Trials studying Cataract
1,114 Patients Enrolled for Cataract
Phillip Brunson, ODPrincipal InvestigatorMann Eye Institute
2 Previous Clinical Trials
70 Total Patients Enrolled
~27 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top